Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic Itch and Neuropathic Pain in Mice.

导出 LinkOut

翻译打印收藏纠错

作者： Ibrahim,Alrashdi ^[1] ; Amal,Alsubaiyel ^[1] ; Michele,Chan ^[1] ; Emma E,Battell ^[2] ; Abdel,Ennaceur ^[3] ; Miles A,Nunn ^[4] ; Wayne,Weston-Davies ^[4] ; Paul L,Chazot ^[5] ; Ilona,Obara ^[1]

作者单位： School of Pharmacy, Newcastle University, Newcastle-upon-Tyne, United Kingdom.;Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom. ^[1] School of Pharmacy, Newcastle University, Newcastle-upon-Tyne, United Kingdom. ^[2] School of Pharmacy, University of Sunderland, Sunderland, United Kingdom. ^[3] Akari Therapeutics Plc, London, United Kingdom. ^[4] Department of Biosciences, Durham University, Durham, United Kingdom. ^[5]

关键词 CNS-sparing Votucalis histamine receptor histamine-binding protein itch mice neuropathic pain

DOI 10.3389/fphar.2022.846683

PMID 35350753

发布时间 2025-02-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Frontiers in pharmacology

2022年13卷

846683页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic Itch and Neuropathic Pain in Mice.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic Itch and Neuropathic Pain in Mice.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除